Latest News

New research shows that while niacin added to statin therapy increases HDL cholesterol levels it does not improve HDL functionality

While two large clinical trials recently showed that adding niacin to statin therapy failed to improve clinical outcomes despite a significant increase in HDL-C levels, little is known about exactly why the increased HDL-C levels did not reduce the risk of cardiovascular events, including heart attack and stroke. Now, a small study has shown that while niacin increased measured levels of HDL-C, it did not improve the functionality of HDL. This may provide an explanation for the failure of niacin to further reduce cardiovascular risk.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Mouse model provides window into working brain

  • Plain cigarette packs don't hurt small retailers or boost trade in illicit tobacco

  • High dietary salt may worsen multiple sclerosis symptoms

  • How Alzheimer's peptides shut down cellular powerhouses

  • Real tremors, or drug-seeking patient? New app can tell

  • Memory and Alzheimer's: Towards a better comprehension of the dynamic mechanisms

  • Nucleotide change could initiate Fragile X Syndrome

  • Childhood trauma could lead to adult obesity

  • Mechanical ventilation a key indicator for Pre-Term Children's maths problems

  • Risk of diabetes in children, adolescents exposed to antipsychotics: Danish 12-year case-control study

  •